Pathology/Lab Coding Alert

Know the Lab Tests Affected


- Published on Sat, Jun 01, 2002




"The new national coverage decisions will impact reimbursement for 65 CPT Codes , which account for approximately 60 percent of laboratory claims, according to the negotiated rulemaking committee that authored the rule," says Laurie Castillo, MA, CPC, CPC-H, CCS-P, member of the national advisory board of the American Academy of Professional Coders (AAPC) and president of Physician Coding and Compliance Consulting in Manassas, Va. The committee which included representatives from CMS and 18 other organizations whose interests may be affected by the rule acted in response to a federal government mandate under the Balanced Budget Act of 1997. The title of each of the 23 policies and the affected CPT codes are listed below:



 






Urine Bacterial Culture 87086, 87088, 87184, 87186



Human Immunodeficiency Virus Testing (Prognosis and Monitoring) 87536, 87539



Human Immunodeficiency Virus Testing (Diagnosis) 86689, 86701, 86702, 86703, 87390, 87391, 87534, 87535, 87537, 87538



Blood Counts (CBC) 85007, 85008, 85013, 85014, 85018, 85021, 85022, 85023, 85024, 85027, 85031, 85048, 85590, 85595



Partial Thromboplastin Time (PTT) 85730



Prothrombin Time (PT) 85610



Serum Iron Studies 82728, 83540, 83550, 84466



Collagen Crosslinks 82523



Blood Glucose Testing 82947, 82948, 82962



Glycated Hemoglobin/Glycated Protein 82985, 83036



Thyroid Testing 84436, 84439, 84443, 84479



Lipids 80061, 82465, 83715, 83716, 83718, 83721,84478



Digoxin Therapeutic Drug Assay 80162



Alpha-fetoprotein (Afp) 82105



Carcinoembryonic Antigen (CEA) 82378



Human Chorionic Gonadotropin (hCG) 84702



Tumor Antigen by Immunoassay for CA 125 86304



Tumor Antigen by Immunoassay for CA 15-3/CA 27.29


86300






Tumor Antigen by Immunoassay for CA 19-9 86301



Prostate Specific Antigen (Total PSA) 84153



Gamma Glutamyltransferase (GGT) 82977



Hepatitis Panel [...]

Pathology/Lab Coding Alert
Issue - Jun, 2002
Already a subscriber? LOGIN to read the article.